Ozempic-style drugs linked to major slowdown in cancer spread, new study finds
A new study from the Cleveland Clinic suggests that GLP-1 weight-loss drugs may significantly slow the progression of certain cancers. The research indicates that patients using these medications experienced up to a 50% reduction in cancer progression for specific tumor types. The findings will be presented at the upcoming ASCO Annual Meeting in Chicago.
- ▪The study involved 12,112 patients with obesity-related cancers.
- ▪Patients taking GLP-1 medications showed lower progression to stage 4 disease compared to those on DPP-4 inhibitors.
- ▪The most notable risk reduction was observed in non-small cell lung cancer, with a 50% decrease in progression.
Opening excerpt (first ~120 words) tap to expand
Health Ozempic-style drugs linked to major slowdown in cancer spread, new study finds Cleveland Clinic study found up to 50% lower progression for some tumor types By Melissa Rudy Fox News Published May 26, 2026 7:00am EDT Facebook Twitter Threads Flipboard Comments Print Email Add Fox News on Google close Video GLP-1 drugs require lifestyle change to work long term as expert warns of potential 'danger' Fox News senior medical analyst Dr. Marc Siegel discusses the benefits and risks of GLP-1 medications on 'Fox & Friends Weekend.' NEWYou can now listen to Fox News articles! Popular GLP-1 (glucagon-like peptide-1) weight-loss drugs may help slow the spread of some cancers, according to new research to be presented at a major medical conference.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Fox News.
Discussion
0 commentsMore from Fox News
